PL EN


Preferences help
enabled [disable] Abstract
Number of results
2010 | 57 | 2 | 153-156
Article title

Effect of carboxymethylated pyridoindoles on free radical-induced haemolysis of rat erythrocytes in vitro

Content
Title variants
Languages of publication
EN
Abstracts
EN
Recently novel carboxymethylated pyridoindoles, analogues of the efficient chain-breaking antioxidant stobadine, have been designed, synthesised and characterised as bifunctional compounds with joint antioxidant/aldose reductase inhibitory activities with the potential of preventing diabetic complications. The critical property for the efficacy of the novel aldose reductase inhibitors in vivo is their ability to penetrate into target tissues. In this study, the issue was addressed by measuring the antioxidant activity of compounds 1 [(2-benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole-8-yl)-acetic acid] and 2 [(±)-2-benzyl-(4a,9b)-cis-1,2,3,4,4a,9b-hexahydro-1H-pyrido[4,3-b] indole-8-yl acetic acid] in the cellular system of intact erythrocytes exposed to peroxyl radicals generated by thermal degradation of the azoinitiator 2,2'-azobis(2-amidinopropane) hydrochloride (AAPH) in vitro. Isolated washed rat erythrocytes were incubated in the presence of the azoinitiator AAPH and the compounds tested for increasing periods of time up to 4 h at 37 °C. The degree of haemolysis was determined by absorbance of the haemoglobin released. The onset of AAPH-induced haemolysis was found to be shifted from the starting zero point by the time interval assigned as a lag period. In the presence of the compounds studied the lag period was prolonged significantly. The free radical-initiated haemolysis was retarded by the compounds studied with decreasing efficiency: stobadine > compound 1 ~ Trolox > compound 2. The results have demonstrated an antioxidant activity of the novel carboxymethylated pyridoindoles developed as potential agents for multitarget pharmacology of diabetic complications.
Publisher

Year
Volume
57
Issue
2
Pages
153-156
Physical description
Dates
published
2010
received
2009-10-07
revised
2009-11-12
accepted
2009-12-16
(unknown)
2010-01-11
Contributors
author
  • Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic
  • Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic
  • Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic
author
  • Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic
References
  • Barclay LR, Artz JD, Mowat JJ (1995) Partitioning and antioxidant action of the water-soluble antioxidant, Trolox, between the aqueous and lipid phases of phosphatidylcholine membranes: 14C tracer and product studies. Biochim Biophys Acta 1237: 77-85.
  • Blois MS (1958) Antioxidant determinations by the use of a stable free radical. Nature 181: 1199-1200.
  • Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54: 1615-1625.
  • Costantino L, Rastelli G, Gamberini MC, Vinson JA, Bose P, Iannone A, Staffieri M, Antolini L, Del Corso A, Mura U, Albasini A (1999) 1-Benzopyran-4-one antioxidants and aldose reductase inhibitors. J Med Chem 42: 1881-1893.
  • Coudert P, Albuisson E, Boire JY, Duroux E, Bastide P, Couquelet J (1994) Synthesis of pyridazine acetic acid derivatives possessing aldose reductase inhibitory activity and antioxidant properties. Eur J Med Chem 29: 471-477.
  • Del Corso A, Cappiello M, Mura U (2008) From a dull enzyme to something else: facts and perspectives regarding aldose reductase. Curr Med Chem 15: 1452-1461.
  • Djoubissie P-O, Snirc V, Sotnikova R, Zurova J, Kyselova Z, Skalska S, Gajdosik A, Javorkova V, Vlkovicova J, Vrbjar N, Stefek M (2006) In vitro inhibition of lens aldose reductase by (2-benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole-8-yl)-acetic acid in enzyme preparations isolated from diabetic rats. Gen Physiol Biophys 25: 415-425.
  • Hamada Y, Araki N, Horiuchi S, Hotta N (1996) Role of polyol pathway in nonenzymatic glycation. Nephrol Dial Transplant 11 (Suppl): 95-98.
  • Juskova M, Snirc V, Gajdosikova A, Gajdosik A, Krizanova L, Stefek M (2010) Carboxymethylated tetrahydropyridoindoles as aldose reductase inhibitors: in vitro selectivity study in intact rat erythrocytes in relation to glycolytic pathway. Gen Physiol Biophys 28: 325-330.
  • Kagan VE, Tsuchiya M, Serbinova E, Packer L, Sies H (1993) Interaction of the pyridoindole stobadine with peroxyl, superoxide and chromanoxyl radicals. Biochem Pharmacol 45: 393-400.
  • La Motta C, Sartini S, Mugnaini L, Simorini F, Taliani S, Salerno S, Marini AM, Da Settimo F, Lavecchia A, Novellino E, Cantore M, Failli P, Ciuffi M (2007) Pyrido[1,2-a] pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity. J Med Chem 50: 4917-4927.
  • Landi L, Cipollone M, Cabrini L, Fiorentini D, Farruggia G, Galli MC (1995) Injury of rat thymocytes caused by exogenous peroxyl radicals in vitro. Biochim Biophys Acta 1239: 207-212.
  • Monnier VM, Mustata GT, Biemel KL, Reihl O, Lederer MO, Zhenyu D, Sell DR (2005) Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on 'a puzzle nearing resolution'. Ann N Y Acad Sci 1043: 533-544.
  • Obrosova IG (2005) Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications. Antioxid Redox Signal 7: 1543-1552.
  • Racková L, Stefek M, Majekova M (2002) Structural aspects of antioxidant activity of substituted pyridoindoles. Redox Rep 7: 207-214.
  • Stenkeen S, Sunquist AR, Jovanovic SV, Crockett R, Sies H (1992) Antioxidant activity of the pyridoindole stobadine. Pulse radiolytic characterisation of one-electron-oxidised stobadine and quenching of singlet molecular oxygen. Chem Res Toxicol 5: 355-360.
  • Stefek M, Masarykova M, Benea L (1992) Inhibition of cumene hydroperoxide-induced lipid peroxidation by a novel pyridoindole antioxidant in rat liver microsomes. Pharmacol Toxicol 70: 407-411.
  • Stefek M, Snirc V, Djoubissie P-O, Majekova M, Demopoulos V, Rackova L, Bezakova Z, Karasu C, Carbone V, El-Kabbani O (2008) Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modelling. Bioorg Med Chem 16: 4908-4920.
  • Winterbourn CC (1990) Oxidative reactions of hemoglobin. Meth Enzymol 186: 265-272.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.bwnjournal-article-abpv57p153kz
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.